US HB5623 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on October 19 2021 - 25% progression, died in committee
Action: 2021-10-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 19 2021 - 25% progression, died in committee
Action: 2021-10-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under part D of Medicare, and for other purposes.
Title
The Insulin Cost Reduction Act
Sponsors
| Rep. Glenn Grothman [R-WI] | Rep. Christopher Jacobs [R-NY] | Rep. Rick Allen [R-GA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-10-19 | House | Referred to the Subcommittee on Health. |
| 2021-10-19 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2021-10-19 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/5623/all-info |
| Text | https://www.congress.gov/117/bills/hr5623/BILLS-117hr5623ih.pdf |
